Replay available

Beta Bionics, Inc. (BBNX) Q3 2025 Earnings Call

Beta Bionics, Inc. (NASDAQ: BBNX) Q3 2025 earnings conference call, held 2025-10-28. Replay captured from the company's public earnings webcast.

Tue, October 28, 2025 at 4:30 PMendedReplay
Beta Bionics, Inc. (BBNX) Q3 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Blake Bieber

Head of Investor Relations

Sean Saint

Chief Executive Officer

Steven Feider

Chief Financial Officer

Mike Kratke

Analyst, Lewink Partners

David Roman

Analyst, Goldman Sachs

Matt O'Brien

Analyst, Piper Sandler

Stephanie Piazzolla

Analyst, Bank of America Securities

Michael Polark

Analyst, Wolfe Research

Frank Takanan

Analyst, Lake Street Capital Markets

Jeff Johnson

Analyst, Baird

Richard Newiter

Analyst, Truist Securities

John Block

Analyst, Stifel

Jeffrey Cohen

Analyst, Ladenburg Thalman & Company

Replay transcript excerpt

Good afternoon, and welcome to the Beta Bionics third quarter 2025 earnings conference call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question-and-answer session, and instructions will follow at that time. As a reminder, please be advised that today's conference is being recorded. I would like to hand the conference over to Blake Bieber, head of investor relations. Please go ahead. Good afternoon, and thank you for tuning in to Beta Bionics third quarter 2025 earnings call. Joining me for today's call are Chief Executive Officer Sean Saint and Chief Financial Officer Steven Feider. Both the replay of this call and the press release discussing our third quarter 2025 results will be available on the investor relations section of our website. The replay will be available for approximately one year following the conclusion of this call. Information recorded on this call speaks only as of today, October 28, 2025. Therefore, if you are listening to any replay, any time sensitive information may no longer be accurate. Also on our website is our supplemental third quarter 2025 earnings presentation and updated corporate presentation. We encourage you to refer to those documents for a summary of key metrics and business updates. Before we begin, we would like to remind you that today's discussion will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements reflect management's expectations about future events, our product pipeline, development timelines, financial performance, and operating plans. Please refer to the cautionary statements in the press release we issued earlier today, as well as our SEC filings, including our Form 10-Q filed ...

More from Beta Bionics, Inc.